Pragmatic Approaches to Improving Insulin Introduction and Integration in T2DM: A Patient Simulation for Frontline Providers
Vivian Fonseca, MD, FRCP
Professor of Medicine
Chief, Section of Endocrinology
Tullis-Tulane Alumni Chair in Diabetes
Tulane University School of Medicine
New Orleans, LA
Timothy S. Reid, MD
Medical Director, Mercy Diabetes Center
Stephanie Larson, PhD
Clinical Content Manager
Rebecca L. Julian, MS, ELS
Senior Manager, Editorial
Laura Muttini, RPh, MBA, CHCP
Chief Operating Officer
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
East Lansing, MI
Upon completion, participants should be able to:
- Evaluate clinical data regarding the timing, efficacy, side effect profiles, and differences in the pharmacologic properties of available long-acting basal insulins
- Integrate strategies to address key reasons for the delayed introduction of insulin therapy including clinician uncertainty and patient-related barriers
This activity is intended for endocrinologists, family medicine physicians, internal medicine physicians, nurse practitioners, and physician assistants.
Statement of Need
The initiation of insulin therapy is frequently delayed in the management of patients with type 2 diabetes mellitus (T2DM), particularly when care is delivered in the primary care setting. Clinicians frequently cite concerns about risks of hypoglycemia and a lack of skills or self-confidence related to insulin initiation or titration as contributing factors. These delays are further amplified by contemporary challenges associated with busy clinical practices, such as being reactive to changing health rather than proactive, as well as by patients’ reluctance to initiate insulin therapy. Reducing the poor health outcomes associated with the delayed use of insulin therefore requires interventions that address both knowledge gaps and practical advice. Exploring the early initiation of insulin therapy in patients with T2DM using a highly interactive simulation-based education provides learning that is both immersive and experiential, allowing clinicians to examine and pragmatically improve their practice patterns while simultaneously minimizing patient risk associated with such experimentation.
Provided by Med-IQ. Powered by ProDoctor.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit
This CME activity consists of a 0.75-credit case simulation. To receive credit, read the introductory CME material, review the case simulation, and complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: July 27, 2018
Expiration Date: July 26, 2019
Estimated Time to Complete This Activity: 45 minutes
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Vivian Fonseca, MD, FRCP
Consulting fees/advisory boards: AstraZeneca, Eli Lilly and Company, Intarcia Therapeutics, Inc., Novo Nordisk, Sanofi-aventis U.S. Inc., Takeda Pharmaceuticals North America, Inc.
Timothy S. Reid, MD
Consulting fees/advisory boards: AstraZeneca, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Novo Nordisk, Sanofi-aventis U.S. Inc.
Fees received for promotional/non-CME activities: Janssen Pharmaceuticals, Inc., Novo Nordisk, Sanofi-aventis U.S. Inc.
Laura Muttini, RPh, MBA, CHCP
Ownership interest (stocks/stock options – excluding mutual funds): Abbott Laboratories, AbbVie Inc.
The peer reviewers and other activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email email@example.com.
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Google Chrome - latest version
Apple Safari - latest version
Adobe Acrobat Reader® or Adobe Reader
Adobe Flash Player
Adobe Flash Player 9 or later
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Sanofi US.
© 2018 Med-IQ, Inc.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.